Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
10163 | 1086 | 43.9 | 85% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
405 | 3 | BACTERIORHODOPSIN//G PROTEIN COUPLED RECEPTOR//G PROTEIN | 29641 |
1079 | 2 | BETA3 ADRENOCEPTOR//ADENYLYL CYCLASE//G PROTEIN | 9902 |
10163 | 1 | ADENYLYL CYCLASE//ABT PHARMAZEUT BIOCHEM//ADENYLYL CYCLASE ISOFORMS | 1086 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ADENYLYL CYCLASE | authKW | 842985 | 22% | 13% | 235 |
2 | ABT PHARMAZEUT BIOCHEM | address | 224918 | 1% | 67% | 12 |
3 | ADENYLYL CYCLASE ISOFORMS | authKW | 165378 | 1% | 59% | 10 |
4 | SOLUBLE ADENYLYL CYCLASE | authKW | 162188 | 1% | 38% | 15 |
5 | P SITE INHIBITOR | authKW | 144593 | 1% | 86% | 6 |
6 | MANT NUCLEOTIDES | authKW | 137763 | 1% | 70% | 7 |
7 | SUPERACTIVATION | authKW | 94696 | 1% | 42% | 8 |
8 | TYPE 5 ADENYLYL CYCLASE | authKW | 89969 | 0% | 80% | 4 |
9 | AC6 | authKW | 84347 | 0% | 100% | 3 |
10 | ADENYLYL CYCLASE TYPE II | authKW | 84347 | 0% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Biochemistry & Molecular Biology | 3429 | 47% | 0% | 513 |
2 | Cell Biology | 889 | 16% | 0% | 176 |
3 | Pharmacology & Pharmacy | 444 | 14% | 0% | 153 |
4 | Neurosciences | 413 | 14% | 0% | 148 |
5 | Biophysics | 364 | 8% | 0% | 83 |
6 | Physiology | 276 | 6% | 0% | 70 |
7 | Substance Abuse | 133 | 2% | 0% | 20 |
8 | Cardiac & Cardiovascular System | 125 | 6% | 0% | 60 |
9 | Biochemical Research Methods | 77 | 4% | 0% | 41 |
10 | Peripheral Vascular Diseases | 70 | 3% | 0% | 34 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ABT PHARMAZEUT BIOCHEM | 224918 | 1% | 67% | 12 |
2 | MOL GR H MOL MODELING | 84347 | 0% | 100% | 3 |
3 | TRI MD PHD PROGRAM | 56920 | 1% | 23% | 9 |
4 | CNRS USTL 5625 | 56231 | 0% | 100% | 2 |
5 | MOL MODELING GR H | 56231 | 0% | 100% | 2 |
6 | VA SAN DIEGO HEALTHCARE SYST 111A | 56231 | 0% | 100% | 2 |
7 | CELL BIOL MOL MED MED CARDIOL | 56227 | 0% | 50% | 4 |
8 | CANC MICROSCOPY SHARED OURCE | 42171 | 0% | 50% | 3 |
9 | HIGH THROUGHPUT SCREENING SPECT OURCE | 37486 | 0% | 67% | 2 |
10 | CELL BIOL MOL MED | 32671 | 2% | 5% | 24 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOLECULAR PHARMACOLOGY | 6586 | 4% | 0% | 48 |
2 | JOURNAL OF BIOLOGICAL CHEMISTRY | 4450 | 14% | 0% | 157 |
3 | CELLULAR SIGNALLING | 2301 | 2% | 0% | 19 |
4 | ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH | 1382 | 2% | 0% | 20 |
5 | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 1027 | 1% | 0% | 11 |
6 | METHODS IN ENZYMOLOGY | 955 | 2% | 0% | 24 |
7 | NEUROSIGNALS | 882 | 0% | 1% | 3 |
8 | AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY | 744 | 1% | 0% | 14 |
9 | JOURNAL OF NEUROCHEMISTRY | 507 | 2% | 0% | 20 |
10 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 501 | 2% | 0% | 20 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ADENYLYL CYCLASE | 842985 | 22% | 13% | 235 | Search ADENYLYL+CYCLASE | Search ADENYLYL+CYCLASE |
2 | ADENYLYL CYCLASE ISOFORMS | 165378 | 1% | 59% | 10 | Search ADENYLYL+CYCLASE+ISOFORMS | Search ADENYLYL+CYCLASE+ISOFORMS |
3 | SOLUBLE ADENYLYL CYCLASE | 162188 | 1% | 38% | 15 | Search SOLUBLE+ADENYLYL+CYCLASE | Search SOLUBLE+ADENYLYL+CYCLASE |
4 | P SITE INHIBITOR | 144593 | 1% | 86% | 6 | Search P+SITE+INHIBITOR | Search P+SITE+INHIBITOR |
5 | MANT NUCLEOTIDES | 137763 | 1% | 70% | 7 | Search MANT+NUCLEOTIDES | Search MANT+NUCLEOTIDES |
6 | SUPERACTIVATION | 94696 | 1% | 42% | 8 | Search SUPERACTIVATION | Search SUPERACTIVATION |
7 | TYPE 5 ADENYLYL CYCLASE | 89969 | 0% | 80% | 4 | Search TYPE+5+ADENYLYL+CYCLASE | Search TYPE+5+ADENYLYL+CYCLASE |
8 | AC6 | 84347 | 0% | 100% | 3 | Search AC6 | Search AC6 |
9 | ADENYLYL CYCLASE TYPE II | 84347 | 0% | 100% | 3 | Search ADENYLYL+CYCLASE+TYPE+II | Search ADENYLYL+CYCLASE+TYPE+II |
10 | TYPE I ADENYLYL CYCLASE | 84347 | 0% | 100% | 3 | Search TYPE+I+ADENYLYL+CYCLASE | Search TYPE+I+ADENYLYL+CYCLASE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SADANA, R , DESSAUER, CW , (2009) PHYSIOLOGICAL ROLES FOR G PROTEIN-REGULATED ADENYLYL CYCLASE ISOFORMS: INSIGHTS FROM KNOCKOUT AND OVEREXPRESSION STUDIES.NEUROSIGNALS. VOL. 17. ISSUE 1. P. 5-22 | 122 | 64% | 107 |
2 | DEFER, N , BEST-BELPOMME, M , HANOUNE, J , (2000) TISSUE SPECIFICITY AND PHYSIOLOGICAL RELEVANCE OF VARIOUS ISOFORMS OF ADENYLYL CYCLASE.AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY. VOL. 279. ISSUE 3. P. F400 -F416 | 118 | 61% | 220 |
3 | KAMENETSKY, M , MIDDELHAUFE, S , BANK, EM , LEVIN, LR , BUCK, J , STEEGBORN, C , (2006) MOLECULAR DETAILS OF CAMP GENERATION IN MAMMALIAN CELLS: A TALE OF TWO SYSTEMS.JOURNAL OF MOLECULAR BIOLOGY. VOL. 362. ISSUE 4. P. 623 -639 | 89 | 71% | 124 |
4 | COOPER, DMF , (2003) REGULATION AND ORGANIZATION OF ADENYLYL CYCLASES AND CAMP.BIOCHEMICAL JOURNAL. VOL. 375. ISSUE . P. 517 -529 | 99 | 59% | 187 |
5 | STEEGBORN, C , (2014) STRUCTURE, MECHANISM, AND REGULATION OF SOLUBLE ADENYLYL CYCLASES - SIMILARITIES AND DIFFERENCES TO TRANSMEMBRANE ADENYLYL CYCLASES.BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. VOL. 1842. ISSUE 12. P. 2535 -2547 | 75 | 65% | 13 |
6 | WILLOUGHBY, D , COOPER, DMF , (2007) ORGANIZATION AND CA2+ REGULATION OF ADENYLYL CYCLASES IN CAMP MICRODOMAINS.PHYSIOLOGICAL REVIEWS. VOL. 87. ISSUE 3. P. 965 -1010 | 136 | 33% | 231 |
7 | BEAZELY, MA , WATTS, VJ , (2006) REGULATORY PROPERTIES OF ADENYLATE CYCLASES TYPE 5 AND 6: A PROGRESS REPORT.EUROPEAN JOURNAL OF PHARMACOLOGY. VOL. 535. ISSUE 1-3. P. 1-12 | 91 | 66% | 47 |
8 | HANOUNE, J , DEFER, N , (2001) REGULATION AND ROLE OF ADENYLYL CYCLASE ISOFORMS.ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY. VOL. 41. ISSUE . P. 145 -174 | 97 | 50% | 391 |
9 | GAO, MH , HAMMOND, HK , (2011) UNANTICIPATED SIGNALING EVENTS ASSOCIATED WITH CARDIAC ADENYLYL CYCLASE GENE TRANSFER.JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY. VOL. 50. ISSUE 5. P. 751 -758 | 70 | 74% | 5 |
10 | PAVAN, B , BIONDI, C , DALPIAZ, A , (2009) ADENYLYL CYCLASES AS INNOVATIVE THERAPEUTIC GOALS.DRUG DISCOVERY TODAY. VOL. 14. ISSUE 19-20. P. 982 -991 | 54 | 86% | 38 |
Classes with closest relation at Level 1 |